|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S2
|
$9,611,397
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S3
|
$3,952
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S4
|
$80,640
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-21S1
|
$27,801
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-21
|
$1,665,362
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group-Statistical Center
|
3U10CA032115-26S1
|
$1,010,519
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Image-Guided System for Cancer Intervention
|
2R42CA115112-02A2
|
$591,060
|
Vosburgh, Kirby
|
ASCENSION TECHNOLOGY CORPORATION
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
PDX-1 is a Therapeutic Target for Pancreatic Cancer
|
2R01CA095731-06A1
|
$274,814
|
BRUNICARDI, FRANCIS
|
BAYLOR COLLEGE OF MEDICINE
|
|
NSABP Participating Sites
|
5U10CA118735-03
|
$66,231
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-03
|
$335,708
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Renal Cancer SPORE
|
3P50CA101942-05S1
|
$1,165,299
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
NIR Fluorescent SLN Mapping for Breast Cancer
|
1R21CA130297-01A1
|
$382,500
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Intraoperative Near-Infrared Fluorescence Imaging
|
5R01CA115296-04
|
$1,217,958
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spatially Modulated Near-Infrared Light for Image-Guided Cancer Surgery
|
5R21CA129758-02
|
$331,361
|
FRANGIONI, JOHN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Circulating Tumor Cells in Non-Small Cell Lung Cancer
|
5R01CA125653-02
|
$337,278
|
Nieva, Jorge
|
BILLINGS CLINIC FOUNDATION
|
|
Long-term Survivorship in Older Women with Early Stage Breast Cancer
|
2R01CA093772-05A2
|
$1,115,875
|
SILLIMAN, REBECCA
|
BOSTON MEDICAL CENTER
|
|
Validation of Prognostic and Diagnostic molecular tests in Mesothelioma
|
5R01CA120528-03
|
$301,617
|
BUENO, RAPHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
NIR Imaging of Sentinel Nodes in Lung Cancer: Finding Micrometastases
|
1R01CA131044-01A1
|
$398,197
|
COLSON, YOLONDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Individual Differences in Pain Modulation as Predictors of Post-Surgical Pain
|
7R21CA120500-02
|
$210,000
|
EDWARDS, ROBERT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-23
|
$327,432
|
IGLEHART, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multidisciplinary Training in Image-Guided Therapy
|
2R25CA089017-06A2
|
$538,479
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Guided Therapy
|
5P01CA067165-10
|
$1,121,902
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MR Guided Focused Ultrasound Surgery for Prostate Cancer
|
5R01CA109246-04
|
$478,840
|
TEMPANY, CLARE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
2U10CA052352-19
|
$575,627
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Assessing the Impact of Colorectal Cancer Screening
|
5U01CA097427-07
|
$215,923
|
RUTTER, CAROLYN
|
CENTER FOR HEALTH STUDIES
|
|
Cancer Research Network Across Health Care Systems
|
5U19CA079689-10
|
$4,846,464
|
WAGNER, EDWARD
|
CENTER FOR HEALTH STUDIES
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Timing of Rectal Cancer Response to Chemoradiation
|
7R01CA090559-07
|
$960,599
|
GARCIA-AGUILAR, JULIO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-21
|
$315,196
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-49
|
$192,303
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-13
|
$873,364
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-25
|
$874,908
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-32
|
$2,367,125
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-07
|
$2,463,000
|
KANTOFF, PHILIP
|
DANA-FARBER CANCER INSTITUTE
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
2U01CA062490-15
|
$613,306
|
KUFE, DONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
Decision-making regarding radiation therapy in breast cancer"
|
5K07CA118269-03
|
$136,890
|
Punglia, Rinaa
|
DANA-FARBER CANCER INSTITUTE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|